PCR vs SCHD
Simplify VettaFi Private Credit Strategy ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. SCHD delivered stronger 1-year returns. PCR offers more diversification with 270 holdings.
Side-by-Side Comparison
| Metric | PCR | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 0.76% | 0.06% | |
| AUM | $2M | $112.2B | |
| Dividend Yield | 10.24% | 3.13% | |
| Holdings | 270 | 103 | |
| YTD Return | -9.18% | +28.33% | |
| 1Y Return | -14.60% | +30.37% | |
| 3Y Return (annualized) | - | +16.64% | |
| 5Y Return (annualized) | - | +10.04% | |
| Volatility (annualized) | 16.2% | 13.6% | |
| Max Drawdown | -20.1% | -33.4% | |
| Fund Family | Simplify Exchange Traded Funds | Charles Schwab Asset Management | |
| Category | Fixed Income | Equity | |
| Inception | Sep 22, 2025 | Oct 20, 2011 |
PCR vs SCHD Performance
Simplify VettaFi Private Credit Strategy ETF (PCR) is a ETF from Simplify Exchange Traded Funds and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Over the past year PCR returned -14.60% while SCHD returned +30.37%. Year to date, PCR is down 9.18% versus a gain of 28.33% for SCHD.
Risk: Volatility and Drawdowns
PCR has been the more volatile fund, with annualized monthly volatility of 16.2% compared with 13.6% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -20.1% for PCR and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at -0.02. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
PCR charges 0.76% per year while SCHD charges 0.06%. On a $10,000 position that is $76 vs $6 annually, a gap of $70 per year that compounds over a long holding period. On income, PCR currently yields 10.24% against 3.13% for SCHD.
Holdings Overlap
PCR and SCHD share 11 holdings out of 346 unique holdings combined, representing a 2.3% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, PCR or SCHD?
PCR has an expense ratio of 0.76% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $70 per year of difference.
Which performed better, PCR or SCHD?
Over the past year PCR returned -14.60% vs +30.37% for SCHD, so SCHD leads on 1-year performance. Past performance does not guarantee future results.
Which is riskier, PCR or SCHD?
PCR has been the more volatile fund at 16.2% annualized versus 13.6% for SCHD. Worst drawdown: PCR -20.1% vs SCHD -33.4%.
Should I hold both PCR and SCHD?
PCR and SCHD have a monthly-return correlation of -0.02, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between PCR and SCHD?
PCR and SCHD share 11 common holdings with a 2.3% weight overlap. Combined, they hold 346 unique securities.
Which pays a higher dividend, PCR or SCHD?
PCR yields 10.24% while SCHD yields 3.13%, so PCR currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.